By Justin Yamashita, MSc. Benchtop, site, CRO: three levels of basic and clinical research, explained without spin.

Where the characters work through the week's evidence.

How the tracks work together: The Root Room is where you watch a bad move actually work on somebody, and where misinformation starts with our version of Black Box Warnings. It shows you how to stay in the room and have a hard health conversation, using the same evidence Plain Talk breaks down and The Informed sources.

Last week we sat in the room watching a drug after it is already approved, and closed by saying we were going somewhere the money is louder. Here we are with the same question, taking enough stages up the clinical research pipeline to get to one of the rooms where it all begins, or doesn’t, where who decides what gets tested at all and whether east versus west makes a difference reside.

"Pho," Marisol says, holding up a little bag of star anise without getting up off the floor of aisle four. "It's the only thing mom can keep down on a chemo week."

"That's not nothing. Just about anything she can keep down is helping right now." Auntie Nani crouches too, which takes her a second longer than it used to. Nani grew up with Marisol's mother in Hawaii, and she has been in the room for every appointment since the diagnosis. To the rest of the Root Room she is Nurse Nani, or Coordinator Nani. Not here. "You got the ginger?"

"Ginger, cinnamon, rock sugar." Marisol turns her phone around. "Can I ask you something dumb?"

On the screen a woman in a flower crown and a long golden dress stands in a kitchen full of afternoon light, holding up a jar of something amber. Fourteen days. Reverses cellular aging. Because it comes from the earth, not a factory.

"Who is that?" Nani says.

"Naturella. Two million followers." Marisol lets the phone drop to her side. "My aunt already bought it. For mom."

Nani doesn't say anything the first time. She watches it again.

"Okay, so, here's my dumb question, since you work in clinical research." Marisol stands up. "If that actually did what she says it does, wouldn't a drug company be selling it by now? They sell everything. They'd put it in a pill and charge me four hundred dollars for it and I'd probably pay. So either it doesn't work, or somebody's sitting on it. And half the comments under that video are saying somebody's sitting on it."

"That is not a dumb question," Nani says. "That is the whole question. People have been arguing about it for about a hundred years."

"So which is it?"

Nani puts the cinnamon in her own basket and stands up. "Let's go look."

The freezer is the size of a shipping container, and it hums.

"Two hundred and thirty thousand," Rooty the Researcher says, and pats the door like a car bonnet. "Extracts of plants, marine organisms, microbes, collected from all over the world. It's one of the biggest collections of its kind anywhere, and it belongs to the National Cancer Institute."

Marisol looks at the freezer for a while. "So somebody is looking at plants."

"Somebody's been looking at plants since before either of you were born." He slides out a tray. Inside it, a flat plastic plate with 384 little wells, each one holding a few drops of something. "They split each extract into fractions first, so you're testing one part at a time instead of a whole soup and guessing which bit did it. They're working toward more than a million fractions."

"And then what?"

"And then they give them away." Rooty slots the tray back. "Any lab that wants to test them against any disease can ask for a set. Free."

Marisol says nothing.

"I know," he says. "If there was a cure sitting in a plant and somebody wanted it buried, this is a strange way to go about it."

Sam the Skeptic has been leaning on the bench this whole time. "Ask him the next part."

"Fine." Marisol turns. "Then why don't we have more plant drugs?"

"Because most of the time you get a signal, you chase it for six months, and it turns out to be something somebody already found in 1974." Rooty says it cheerfully. "There's a name for it. Dereplication. You check whether your exciting new thing is a known compound wearing a different hat, and usually it is."

"That's depressing," Marisol says.

"That's most of science," Rooty says.

Nani has been quiet. "And when it isn't already known?"

"Then you're at the start of about a decade of work and a few hundred million dollars, and that's if nothing goes wrong, which it often does." Rooty shrugs. "Somebody has to want to pay for that."

"And nobody can own a plant," Marisol says slowly.

"Nobody can own ginger," Nani agrees. "Somebody can own a thing they built out of ginger in a lab, because that's different enough to belong to them. But the ginger itself is just ginger."

"So it isn't that nobody looked."

"It's that nobody's job was to finish," Nani says. "Which is a worse answer in some ways. But it's the true one, and unlike a cover-up, it's the kind of thing that can be fixed. Wednesday I'll show you who actually pays when nobody can own the answer. It's a shorter list than you'd think."

Marisol looks at her phone, still face-up on the bench where she set it down. "The comments said it was buried."

"Ask them which freezer," Sam says.

On the way out Marisol says, "It's a plant, though. That's been the whole thing for me. It grows."

Sam steps in front of the door and puts two boxes on the shelf beside it, side by side, no ceremony. "Digoxin. Comes out of a foxglove, and at the wrong dose it will stop your heart. Amlodipine. Got made in a building off the interstate, and people take it every day for thirty years." Sam straightens up. "Which one did knowing where it came from tell you about?"

Marisol looks at the boxes for a second longer than she means to.

"And here's the part that actually worries me," Nani says, holding the door open with her hip. "When nobody finishes the work, nobody writes down what it doesn't mix with. Somebody brings me a jar and asks if it's okay with what they're already taking. Sometimes I can look it up. Grapefruit juice and half the pharmacy, that one's known. Most of what comes through that door, I can't tell them, and it's not because I'm not allowed to. It's because nobody did it."

"That's worse than being told no," Marisol says.

"It is." Nani lets the door start to swing, then catches it. "Which is why that jar doesn't go anywhere near your mother until her oncology team has seen the label. Not the website. The actual label, every ingredient on it. Her pharmacist too, they're better at this than anyone gives them credit for."

"And if they say they don't know?"

"Then they don't know, and that's your answer for now," Nani says. "Nobody knowing is a reason to wait. It has never once been a reason to go ahead."

She lets the door go. "Here's the one I'd hold onto. If someone tells you they're burying natural cures, ask them why the exact same thing happens to a sixty-year-old generic pill that nobody is hiding from anybody. Same problem, same reason. If the story only works for plants, it stopped being about money a while ago."

The counter is the one Sam ran at the door. Natural is not a safety claim. Hemlock is natural. So what's the evidence? Set the thing that grew next to the thing that got built, and ask which one knowing the origin actually told you about.

Next issue: Non Animal Models (NAMs) and the lab where the next generation of preclinical testing happens without an animal in the room.

Send this to someone who thinks "they'll never study that" means "they don't want to know."

This week's Plain Talk runs what a new drug actually costs to prove, and why ownership rather than intent decides what gets studied, including who does pay when nobody can own the answer.

Want the full science? Thursday's Informed covers the patent rule, the trial economics, and the one remedy out of an old text that made it all the way through, including who actually paid for it.

New here? Root to Rx runs three pieces a week. Monday you watch a real health claim try to work on someone. Wednesday you get the tools to run it yourself. Thursday you get the full evidence so you can check my work. Written by a clinical researcher, free, at RootToRx.com.

For educational purposes only. Nothing in this newsletter is medical advice. Talk to your doctor before making any health decision.

Instagram: instagram.com/roottorx  |  LinkedIn: linkedin.com/company/roottorx  |  Facebook Lab: facebook.com/groups/theroottorxlab  |  Subscribe: RootToRx.com

You are receiving this because you subscribed at roottorx.com.

Disclosure: Root to Rx is published independently by Open Label Media LLC. Views expressed are personal views of Justin Yamashita and do not represent his employer or any affiliated organization. No employer resources or proprietary information are used. Every claim is sourced from publicly available materials.

Root to Rx | 228 Park Ave S, #29976, New York, New York 10003, United States